Matthew Christian Lind

Title: Matthew Christian Lind: Innovator in Electrophoresis Technology

Introduction

Matthew Christian Lind is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of disease detection through innovative electrophoresis techniques. With a total of 2 patents, Lind's work is paving the way for advancements in medical diagnostics.

Latest Patents

Lind's latest patents focus on using electrophoresis for disease detection based on controlled molecular charge. This method identifies the presence of a target compound in a patient sample by analyzing the charge state of the compound and a label. The charge state correlates to the total net charge of a binder conjugated to the compound. The labeled bound complex is applied to an electrophoresis substrate, where an electric potential is used to facilitate migration toward the electrode with the opposite charge. This process results in a migration pattern that can be analyzed to identify the presence of the compound based on the labeled bound complex band.

Career Highlights

Matthew Lind is currently associated with Hemex Health, Inc., where he continues to develop innovative solutions in the healthcare sector. His work is instrumental in enhancing the accuracy and efficiency of disease detection methods.

Collaborations

Lind collaborates with talented professionals such as Peter M Galen and Ariane Elizabeth Erickson, contributing to a dynamic and innovative work environment.

Conclusion

Matthew Christian Lind's contributions to electrophoresis technology are significant and impactful. His innovative approaches are set to improve disease detection methods, showcasing the importance of research and development in healthcare.